Anoctamin1 (ANO1) is a calcium-activated chloride channel (CaCC) that is widely expressed in a variety of human carcinomas, including head and neck squamous cell carcinoma, esophageal squamous cell carcinoma, oral cancer, breast cancer, and prostate cancer17–22. This evidence concerns the gene ANO1 and esophageal squamous cell carcinoma.